NOUGUES MAXIMO F 4
4 · PUMA BIOTECHNOLOGY, INC. · Filed Nov 4, 2022
Insider Transaction Report
Form 4
NOUGUES MAXIMO F
Chief Financial Officer
Transactions
- Sale
Common Stock
2022-11-02$2.25/sh−163$367→ 111,085 total
Footnotes (1)
- [F1]The sales reported in this Form 4 were to satisfy tax obligations in connection with the vesting of restricted stock units in accordance with the Company's mandatory sale to cover taxes program.